CD146-targeted CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD146-targeted CAR T cells, covering 2025-07-15 to 2025-07-15. Get the full timeline:
Most recent: Clinical Trial Update: Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas [Phase 1, Phase 2]